ICICI Prudential Value Discovery Fund - Direct Plan - Growth

Constituent Forensic Metrics & Solvency Look-Through

Forensic Desk 🔄 Re-Audit Look-Through

Audit in Desk ↗

Audit in Desk ↗

Audit in Desk ↗

Audit in Desk ↗

Identifier	Security Name	Type	Weight	Sector / Rating	Engine Score	Diagnostic Notes
TREPS	TREPS Cash Reserve	CASH_EQUIVALENT	19.5%	CASH	100.0	Liquid Cash / Sovereign Collateral
ICICIBANK ↗	ICICI Bank Ltd	EQUITY	8.5%	Private Banks	82.0	Verified 7-Pillar Equity Dossier Available
BHARTIARTL ↗	Bharti Airtel Ltd	EQUITY	6.2%	Telecom	82.0	Verified 7-Pillar Equity Dossier Available
INFY ↗	Infosys Ltd	EQUITY	5.5%	IT Services	82.0	Verified 7-Pillar Equity Dossier Available
ITC ↗	ITC Ltd	EQUITY	4.5%	FMCG	82.0	Verified 7-Pillar Equity Dossier Available
SUNPHARMA ↗	Sun Pharmaceutical Ind	EQUITY	4.1%	Pharmaceuticals	82.0	Verified 7-Pillar Equity Dossier Available

High Active Share: Portfolio significantly deviates from the passive benchmark, justified active fee.

Time Horizon	Direct Plan Value (Net)	Regular Plan Value (Net)	Cumulative Wealth Lost	Percentage Corpus Destroyed
5 Years	₹1,701,823	₹1,641,492	-₹60,331	3.5%
10 Years	₹2,896,202	₹2,694,495	-₹201,707	7.0%
15 Years	₹4,928,825	₹4,422,992	-₹505,833	10.3%
20 Years	₹8,387,988	₹7,260,305	-₹1,127,683	13.4%

Audited: 2026-10-09 10:14

# INSTITUTIONAL FORENSIC DOSSIER: ICICI Prudential Value Discovery Fund - Direct Plan - Growth --- ## 1. Mandate Integrity vs Ground Reality (Active Share & Style Drift) The fund operates with an **Active Share of 65.0%** against the NIFTY 500 TRI benchmark. Within institutional asset management frameworks, an Active Share in the 60%–70% band sits on the boundary between an active mandate and structural closet indexing. * **Active Risk vs. Return Budgeting:** At 65%, nearly two-thirds of the portfolio diverges from the benchmark weights. While this confirms the fund is not an expensive index tracker, it also indicates that one-third of the portfolio is anchored to benchmark constituents. For a value/contra mandate designed to exploit mispricings, a higher Active Share (>75%) is theoretically expected to capture deep-value dislocations. * **AUM Capacity Drag:** Managing an asset base of **₹46,200 Cr** creates distinct market impact costs, particularly for a value-oriented strategy that frequently accumulates out-of-favor, mid-cap, or illiquid cyclical assets. At this capital scale, position sizing is constrained by average daily traded volumes (ADTV). The manager cannot build meaningful positions in true micro-cap or deep-value small-caps without violating single-counterparty liquidity thresholds (e.g., holding <5% of the company’s free float to avoid exit paralysis). Consequently, the portfolio is structurally forced up-cap toward large-cap and liquid mid-cap compounders, diluting the purity of the "Value/Contra" mandate and introducing style drift toward large-cap growth-at-a-reasonable-price (GARP). * **Turnover Discipline:** A portfolio turnover ratio of **38.0%** implies an average holding period of roughly 2.6 years. This aligns with a patient value horizon, allowing capital to realize mean-reversion without incurring excessive transaction friction or signaling short-term momentum trading. --- ## 2. Forensic Solvency & Accounting Fragility (ASRI Analysis) * **Accounting & Solvency Risk Index (ASRI):** The portfolio records an ASRI of **0.0%**, indicating that zero capital is deployed in enterprises flagged for aggressive revenue recognition, questionable related-party transactions, unhedged foreign currency liabilities, or severe working capital inflation. * **Promoter Pledging:** Promoter pledging stands at **0.0%**, eliminating the systemic tail-risk of margin-call-induced equity cascades during broader market drawdowns. * **Forensic Ledger Scan ("None Detected"):** The absolute absence of leveraged or forensic red flags across the top-tier holdings reflects a rigorous quality filter. In typical value mandates, managers often fish in distressed waters, exposing portfolios to value traps characterized by high financial leverage and deteriorating cash-flow conversion. Here, the fund deliberately avoids distressed balance sheets, restricting its value hunting to companies experiencing cyclical troughs rather than structural balance-sheet insolvency. This protects the portfolio from sudden value destruction via debt default or equity dilution. --- ## 3. Economic Moat & Intrinsic Margin of Safety (DCF Capital Moat) * **Weighted Economic Moat Index:** Scoring **92.0/100**, the portfolio exhibits elite structural defenses. The underlying holdings possess deep competitive advantages, including high switching costs, network effects, and cost leadership. * **Intrinsic Margin of Safety:** The weighted DCF margin of safety rests at a modest **8.9%**. * **The Valuation-Quality Tension:** The portfolio's high moat score (92.0) combined with a narrow margin of safety (8.9%) signals that the market is efficiently pricing the quality of these assets. The core compounders—**ICICI Bank Ltd, Bharti Airtel Ltd, Infosys Ltd, ITC Ltd, and Sun Pharmaceutical Industries Ltd**—are premier institutional allocations. However, acquiring high-moat businesses within a value mandate often proves mathematically contradictory: true economic moats command valuation premiums, leaving thin margins of safety. ``` [Portfolio Moat: 92/100 (Elite Quality)] vs. [DCF Margin of Safety: 8.9% (Thin Buffer)] = [High-Quality Compounder Exposure Trading Near Fair Value] ``` * **Asset Breakdown Analysis:** * *ICICI Bank Ltd:* Structural deposit franchise and provisioned balance sheet; trades close to intrinsic fair value multiples. * *Bharti Airtel Ltd:* Telecommunications duopoly pricing power; capital expenditure cycle peaking, expanding free cash flow (FCF). * *Infosys Ltd:* Global delivery scale and high return on capital employed (ROCE); valuation reflects steady-state discretionary IT spending recovery. * *ITC Ltd:* Cigarette cash-cow monopoly combined with FMCG/hotel scale; historically discounted due to ESG overlays, now rerated closer to intrinsic value. * *Sun Pharmaceutical Ind:* Specialized complex generics and domestic cash generation; regulatory risks priced efficiently. The thin 8.9% margin of safety implies that the portfolio possesses limited downside shock absorption if macro discount rates rise or earnings growth decelerates relative to DCF assumptions. --- ## 4. Manager Fee Justification vs Passive Index Drag * **Expense Architecture:** * Direct Plan Total Expense Ratio (TER): **0.78%** * Regular Plan Total Expense Ratio (TER): **1.58%** * Commission Spread / Intermediary Drag: **0.80% per annum** ``` +-----------------------------------------------------------------+ | 15-YEAR ACCUMULATED DISTRIBUTION DRAG | | | | [Regular Plan: 1.58%] ======================> Higher Drag | | [Direct Plan: 0.78%] ===========> Optimal Net Return | | (0.80% Annual Commission Differential) | +-----------------------------------------------------------------+ ``` * **Fiduciary Audit of the 0.8% Spread:** Over a 15-year institutional compounding horizon, an annual 80-basis-point distribution fee represents a severe drag on net terminal wealth. * **Active Return Hurdle:** To justify the Direct Plan’s 0.78% TER over a low-cost NIFTY 500 passive ETF/index fund (typically charging <0.10%), the active strategy must generate an annualized alpha exceeding **~0.70% net of taxes and transaction costs** persistently across market cycles. Given the 65% Active Share and the ₹46,200 Cr AUM capacity drag, clearing this hurdle requires superior stock selection rather than structural beta exposure. * **Regular Plan Assessment:** The Regular Plan’s 1.58% TER imposes an aggressive hurdle. Institutional mandates categorically reject the Regular Plan structure due to the uncompensated agency drag paid to intermediaries, which structurally impairs long-term compounding. --- ## 5. Pre-Mortem Scenario: What Breaks in a Severe Market Stress Test? Assume a systemic liquidity contraction where secondary market trading volumes drop by 30%, accompanied by a macro shock driving a 20% index drawdown. The structural vulnerabilities of ICICI Prudential Value Discovery Fund under these conditions are modeled below: ### A. Liquidity Bottleneck & Impact Costs * **The AUM Scale Vulnerability:** At ₹46,200 Cr, unwinding non-benchmark or mid-cap cyclical holdings during a liquidity squeeze will induce severe market impact costs. * **Execution Friction:** While the top holdings (e.g., ICICI Bank, Bharti Airtel, Infosys) feature massive ADTVs and can absorb institutional block trades, the value/contra allocation often includes out-of-favor mid-caps. Under a 30% liquidity contraction, bid-ask spreads for these secondary holdings will widen exponentially. Forced portfolio rebalancing or meeting redemption requests would require selling the most liquid assets first, resulting in a residual portfolio skewed toward illiquid value traps. ### B. Sector Concentration & Cyclical Unwinding * **Value Trap Exposure during Macro Contraction:** Value and contra strategies rely on the eventual mean-reversion of cyclical sectors (e.g., industrials, corporate lenders, commodities). In a severe economic stress test, cyclical earnings estimates are revised downward aggressively. * **Valuation Compression:** Because the portfolio operates with an 8.9% margin of safety, it lacks a sufficient valuation cushion. A macro earnings contraction would compress multiples across holdings simultaneously, neutralizing the thesis that low valuations protect capital during drawdowns. ### C. Factor Risk * **The "Fake Value" Risk:** If the market shifts toward prolonged risk-off behavior, high-moat compounders with low margins of safety can experience sharp de-ratings as investors flee to sovereign paper or cash equivalents. The combination of a thin DCF margin of safety and a 65% Active Share means the fund will likely track the broader equity drawdown while lacking the aggressive downside protection of cash buffers or deep-discount asymmetry.